GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello A/S (STU:4AJ0) » Definitions » E10

Alk-Abello A/S (STU:4AJ0) E10 : €0.12 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Alk-Abello A/S E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Alk-Abello A/S's adjusted earnings per share data for the three months ended in Mar. 2024 was €0.148. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.12 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Alk-Abello A/S's average E10 Growth Rate was 30.50% per year. During the past 3 years, the average E10 Growth Rate was 14.50% per year. During the past 5 years, the average E10 Growth Rate was 1.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Alk-Abello A/S was 14.50% per year. The lowest was -51.70% per year. And the median was -5.40% per year.

As of today (2024-06-19), Alk-Abello A/S's current stock price is €18.93. Alk-Abello A/S's E10 for the quarter that ended in Mar. 2024 was €0.12. Alk-Abello A/S's Shiller PE Ratio of today is 157.75.

During the past 13 years, the highest Shiller PE Ratio of Alk-Abello A/S was 379.56. The lowest was 8.09. And the median was 163.70.


Alk-Abello A/S E10 Historical Data

The historical data trend for Alk-Abello A/S's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alk-Abello A/S E10 Chart

Alk-Abello A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.06 0.06 0.11 0.13

Alk-Abello A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.16 0.16 0.13 0.12

Competitive Comparison of Alk-Abello A/S's E10

For the Biotechnology subindustry, Alk-Abello A/S's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alk-Abello A/S's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alk-Abello A/S's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Alk-Abello A/S's Shiller PE Ratio falls into.



Alk-Abello A/S E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Alk-Abello A/S's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.148/118.4000*118.4000
=0.148

Current CPI (Mar. 2024) = 118.4000.

Alk-Abello A/S Quarterly Data

per share eps CPI Adj_EPS
201406 0.021 99.700 0.025
201409 0.018 99.700 0.021
201412 0.011 99.400 0.013
201503 0.061 100.200 0.072
201506 0.034 100.300 0.040
201509 0.040 100.200 0.047
201512 0.093 99.800 0.110
201603 0.080 100.200 0.095
201606 0.047 100.600 0.055
201609 0.027 100.200 0.032
201612 0.024 100.300 0.028
201703 0.001 101.200 0.001
201706 -0.001 101.200 -0.001
201709 -0.016 101.800 -0.019
201712 -0.099 101.300 -0.116
201803 0.015 101.700 0.017
201806 -0.011 102.300 -0.013
201809 -0.016 102.400 -0.019
201812 -0.091 102.100 -0.106
201903 0.027 102.900 0.031
201906 -0.041 102.900 -0.047
201909 -0.019 102.900 -0.022
201912 -0.008 102.900 -0.009
202003 0.052 103.300 0.060
202006 -0.006 103.200 -0.007
202009 -0.012 103.500 -0.014
202012 -0.019 103.400 -0.022
202103 0.078 104.300 0.089
202106 -0.013 105.000 -0.015
202109 0.023 105.800 0.026
202112 0.046 106.600 0.051
202203 0.094 109.900 0.101
202206 0.027 113.600 0.028
202209 0.027 116.400 0.027
202212 0.042 115.900 0.043
202303 0.094 117.300 0.095
202306 0.040 116.400 0.041
202309 0.067 117.400 0.068
202312 0.080 116.700 0.081
202403 0.148 118.400 0.148

Add all the adjusted EPS together and divide 10 will get our e10.


Alk-Abello A/S  (STU:4AJ0) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Alk-Abello A/S's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=18.93/0.12
=157.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Alk-Abello A/S was 379.56. The lowest was 8.09. And the median was 163.70.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Alk-Abello A/S E10 Related Terms

Thank you for viewing the detailed overview of Alk-Abello A/S's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Alk-Abello A/S (STU:4AJ0) Business Description

Address
Boge Alle 6-8, Horsholm, DNK, DK-2970
Alk-Abello A/S is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication.

Alk-Abello A/S (STU:4AJ0) Headlines

No Headlines